+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Live Cell Encapsulation - Global Strategic Business Report

  • PDF Icon

    Report

  • 94 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302806
The global market for Live Cell Encapsulation was estimated at US$300.2 Million in 2023 and is projected to reach US$388.1 Million by 2030, growing at a CAGR of 3.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Live Cell Encapsulation Market - Key Trends and Drivers Summarized

How Is Live Cell Encapsulation Advancing Regenerative Medicine?

Live cell encapsulation is an innovative biotechnology technique used to enclose living cells in a protective matrix, allowing them to survive and function inside the body while shielding them from the host's immune system. This technique is being explored as a powerful tool in regenerative medicine, with applications ranging from diabetes treatment to neurodegenerative diseases. Encapsulated cells can secrete therapeutic molecules or even act as replacements for damaged tissue without requiring immunosuppressive drugs. For example, in diabetes management, encapsulated islet cells can continuously produce insulin, offering a potential alternative to insulin injections. Live cell encapsulation holds promise for a future where cell therapies could become a routine treatment for chronic diseases.

What Technological Innovations Are Driving Live Cell Encapsulation?

Technological advancements in biomaterials and encapsulation techniques are critical in enhancing the effectiveness of live cell encapsulation. Biocompatible materials like alginate, chitosan, and synthetic polymers are used to form the capsules that protect the cells while allowing nutrients and therapeutic agents to pass through. Innovations such as microencapsulation and nanofiber scaffolds are improving the stability and function of encapsulated cells, ensuring long-term viability in the body. Recent breakthroughs in 3D bioprinting are also being applied to develop customized encapsulation structures, improving precision in the placement and delivery of therapeutic cells. These technological advancements are opening new doors for encapsulation in personalized medicine and chronic disease management.

How Do Market Segments Define the Growth of Live Cell Encapsulation?

Applications include regenerative medicine, cell transplantation, and drug delivery, with regenerative medicine leading the market due to its potential in treating chronic conditions such as diabetes, liver diseases, and neurodegenerative disorders. Material types include natural polymers like alginate and synthetic materials, with natural polymers being the most widely used due to their biocompatibility and ease of modification. End-users include research institutions, biotechnology companies, and pharmaceutical firms, with biotechnology companies driving significant demand as they develop new cell-based therapies. Geographically, North America and Europe dominate the market due to their robust biotech ecosystems and ongoing clinical trials.

What Factors Are Driving the Growth in the Live Cell Encapsulation Market?

The growth in the live cell encapsulation market is driven by several factors, including the rising demand for regenerative medicine, advancements in biomaterial science, and increasing investment in cell-based therapies. As the prevalence of chronic diseases such as diabetes and neurodegenerative disorders continues to rise, live cell encapsulation offers a promising alternative to traditional treatments. Additionally, ongoing research into biocompatible materials and encapsulation techniques is improving the safety and efficacy of these therapies. Regulatory approvals for encapsulated cell therapies are further bolstering market growth, as more companies bring innovative treatments to clinical trials and commercialization stages.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Alginate Polymer segment, which is expected to reach US$117.8 Million by 2030 with a CAGR of a 4.4%. The Chitosan Polymer segment is also set to grow at 3.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $79.7 Million in 2023, and China, forecasted to grow at an impressive 5.8% CAGR to reach $80.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Live Cell Encapsulation Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Live Cell Encapsulation Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Live Cell Encapsulation Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Live Cell Encapsulation market such as Altucell, Inc., Beta-O2 Technologies Ltd, Biotime, Inc., Blacktrace Group, Büchi Labortechnik AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 43 companies featured in this Live Cell Encapsulation market report include:

  • Altucell, Inc.
  • Beta-O2 Technologies Ltd
  • Biotime, Inc.
  • Blacktrace Group
  • Büchi Labortechnik AG
  • Defymed
  • Evonik Industries
  • Gloriana Therapeutics
  • Kadimastem
  • Living Cell Technologies
  • Neurotech Holdings, LLC.
  • Pharmacyte Biotech, Inc.
  • Sernova Corporation
  • Sigilon Therapeutics
  • Viacyte, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Live Cell Encapsulation - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Cell-Based Therapies Spurs Growth in Live Cell Encapsulation Market
  • Technological Advancements in Biomaterials and Encapsulation Techniques Strengthen Business Case for Adoption
  • Growing Use of Live Cell Encapsulation in Diabetes and Pancreatic Disorders Expands Addressable Market
  • Increasing Focus on Improving Cell Viability and Long-Term Function Drives Demand for Encapsulation Solutions
  • Rising Adoption of Live Cell Encapsulation in Gene Therapy Expands Market Opportunities
  • Technological Innovations in Immuno-Isolation and Biocompatible Materials Propel Market Growth
  • Growing Use of Live Cell Encapsulation in Organ Transplantation and Tissue Engineering Expands Market Potential
  • Focus on Minimizing Immune Rejection and Enhancing Therapeutic Efficacy Drives Demand for Advanced Encapsulation Technologies
  • Expansion of Personalized Medicine Applications Fuels Demand for Encapsulation Technologies
  • Increasing Use of Live Cell Encapsulation in Cancer Immunotherapy Expands Market Opportunities
  • Technological Advancements in Microencapsulation and Macroencapsulation Techniques Propel Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Live Cell Encapsulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Live Cell Encapsulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Live Cell Encapsulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Alginate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Alginate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Alginate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Chitosan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Chitosan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Chitosan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for HEMA-MMA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for HEMA-MMA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for HEMA-MMA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Siliceous Encapsulates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Siliceous Encapsulates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Siliceous Encapsulates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cellulose Sulfate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Cellulose Sulfate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Cellulose Sulfate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for PAN-PVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for PAN-PVC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for PAN-PVC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other Polymer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Other Polymer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Other Polymer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Cell Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 26: World Historic Review for Cell Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 27: World 16-Year Perspective for Cell Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 29: World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 30: World 16-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 32: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 33: World 16-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 35: World Historic Review for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 36: World 16-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 37: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 38: World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 39: World 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 40: World Live Cell Encapsulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Live Cell Encapsulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Altucell, Inc.
  • Beta-O2 Technologies Ltd
  • Biotime, Inc.
  • Blacktrace Group
  • Büchi Labortechnik AG
  • Defymed
  • Evonik Industries
  • Gloriana Therapeutics
  • Kadimastem
  • Living Cell Technologies
  • Neurotech Holdings, LLC.
  • Pharmacyte Biotech, Inc.
  • Sernova Corporation
  • Sigilon Therapeutics
  • Viacyte, Inc.

Table Information